Sign up to save your podcasts
Or
Share Healthify swallowed its disruptors. But can it digest them?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Healthify swallowed its disruptors. But can it digest them?
Every great Indian enterprise has a story worth telling in full.
With The Intermission, The Ken's flagship long-form podcast, hosts Rohin Dharmakumar and Seetharaman G do exactly that—tracing the origins, turning points, and defining strategies of the companies that shaped modern India.
Built on exhaustive research and proprietary interviews, each episode unfolds as a richly reported narrative.
Stay tuned!
Most businesses die quietly. They miss a wave, lose relevance and fade out.
Healthify nearly got hit by two in quick succession. First, AI that could do what took the company years to build. Then, a drug which meant you didn't need the discipline anymore.
So Rahel Philipose and Praveen Gopal Krishnan asked Tushar Vashisht, Healthify's co-founder and CEO, the uncomfortable question directly: if anyone can build an AI coach and a drug can kill your appetite, what exactly are you selling?
This episode is really about three things most people don't know.
One, why people who take Ozempic without a lifestyle program gain almost all the weight back within a year.
Two, what actually happens to a platform business when AI replaces one entire side of it.
And three, why Tushar believes his most dangerous competitor hasn't been founded yet.
We were also joined by Professor R Srinivasan from IIM Bangalore, who had a very different read on whether Healthify's bet is genius or cope.
_____
This episode was produced by Uddantika Kashyap and mixed and mastered by Rajiv CN, our resident sound engineer.
If you liked this episode, share it with your friends, family and colleagues. And if you have thoughts on the discussion, write to us at [email protected].
🚨The Ken's Zero Shot podcast is hosting a live event! This is a speculative yet realistic discussion built around one premise: what happens when AI agents take off in India? How will they rewire existing habits, business models and profit pools? Since nobody knows for sure, we won't pretend to have all the answers. Instead we are going to break the narrative. Click here for details.
View all episodes
By The KenEvery great Indian enterprise has a story worth telling in full.
With The Intermission, The Ken's flagship long-form podcast, hosts Rohin Dharmakumar and Seetharaman G do exactly that—tracing the origins, turning points, and defining strategies of the companies that shaped modern India.
Built on exhaustive research and proprietary interviews, each episode unfolds as a richly reported narrative.
Stay tuned!
Most businesses die quietly. They miss a wave, lose relevance and fade out.
Healthify nearly got hit by two in quick succession. First, AI that could do what took the company years to build. Then, a drug which meant you didn't need the discipline anymore.
So Rahel Philipose and Praveen Gopal Krishnan asked Tushar Vashisht, Healthify's co-founder and CEO, the uncomfortable question directly: if anyone can build an AI coach and a drug can kill your appetite, what exactly are you selling?
This episode is really about three things most people don't know.
One, why people who take Ozempic without a lifestyle program gain almost all the weight back within a year.
Two, what actually happens to a platform business when AI replaces one entire side of it.
And three, why Tushar believes his most dangerous competitor hasn't been founded yet.
We were also joined by Professor R Srinivasan from IIM Bangalore, who had a very different read on whether Healthify's bet is genius or cope.
_____
This episode was produced by Uddantika Kashyap and mixed and mastered by Rajiv CN, our resident sound engineer.
If you liked this episode, share it with your friends, family and colleagues. And if you have thoughts on the discussion, write to us at [email protected].
🚨The Ken's Zero Shot podcast is hosting a live event! This is a speculative yet realistic discussion built around one premise: what happens when AI agents take off in India? How will they rewire existing habits, business models and profit pools? Since nobody knows for sure, we won't pretend to have all the answers. Instead we are going to break the narrative. Click here for details.